27 agosto 2009

Eficacia y seguridad del Yondelis en Pacientes con LipoSarcoma / LeiomioSarcoma avanzado o metastásico ... ¡¡ No cumulative toxicities were noted !! .

Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules.

...

Yondelis may now be considered an important new option to control advanced sarcomas in patients after failure of available standard-of-care therapies.

...